Estuary Biotherapeutics has swum out of stealth with $103 million in funding to power a pair of gene therapies into clinical ...
The Series A round, which was led by RA Capital, will help fund the development of two genetic medicines designed to treat an ...
Estuary is now plotting human trials that will begin in 2027 and 2028. The first will test EST-201, a Pkd2 gene therapy for ...
Estuary Biotherapeutics has launched with $103 million in committed financing to develop genetic medicines targeting serious ...
US genetic medicines developer Estuary Biotherapeutics today announced its launch with $103 million in total committed ...
A three-year study in Demak, Central Java shows that mangrove restoration combined with bamboo barriers can rebuild sinking ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results